Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer...

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Dendritic cell (DC)-based cancer vaccines have shown limited clinical success for over two decades.
• A key limitation is the absence of standardized protocols for generating clinical-grade DC vaccines that elicit effective anti-tumor immunity.
• Bacterial Ghosts (BGs), empty bacterial envelopes, present a potential solution due to their adjuvant properties and antigen-loading capacity.

Purpose of the Study:

• To investigate Bacterial Ghosts (BGs) as a platform for optimizing the production of dendritic cell (DC) vaccines.
• To compare the efficacy of BG-based DC maturation and antigen loading with traditional methods using lipopolysaccharide (LPS) and interferon-γ (IFN-γ).

Main Methods:

• Human monocyte-derived DCs were generated and matured using either the BG platform or a standard LPS + IFN-γ cocktail.
• DCs were loaded with tumor lysate as a source of tumor antigens.
• Phenotype, cytokine secretion, functional activity, and T-cell responses in vitro were compared between BG-matured and LPS-matured DCs.

Main Results:

• Both BG and LPS methods induced DC maturation, but the BG protocol resulted in DCs with lower tolerogenic potential.
• BG-matured DCs demonstrated superior CD8+ T cell activation and functional activity compared to LPS-matured DCs.
• The BG approach significantly reduced the induction of regulatory T cells and showed resistance to immunosuppressive tumor lysates.

Conclusions:

• Bacterial Ghosts provide an effective, single-step platform for generating immunogenic DC vaccines with reduced tolerogenic properties.
• BG-based DC vaccines show enhanced potential for robust anti-tumor T-cell responses compared to conventional LPS-based methods.
• This optimized protocol offers a standardized approach to improve the clinical efficacy of DC-based cancer immunotherapy.